Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda to sell diabetes products portfolio to Teijin Pharma for $1.25bn

pharmaceutical-technologyMarch 02, 2021

Tag: Takeda , Teijin Pharma , Teijin , Diabetes

PharmaSources Customer Service